Published in Crit Care on November 29, 2013
Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearance. Curr Infect Dis Rep (2015) 0.81
Prolonged versus Intermittent Infusion of β-Lactams for the Treatment of Nosocomial Pneumonia: A Meta-Analysis. Infect Chemother (2016) 0.76
Is there a role for continuous infusion of β-lactam antibiotics in severe sepsis? J Thorac Dis (2016) 0.75
Pharmacokinetic considerations and dosing strategies of antibiotics in the critically ill patient. J Intensive Care Soc (2015) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
APACHE II: a severity of disease classification system. Crit Care Med (1985) 69.83
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA (1994) 27.36
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98
Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol (2005) 10.99
Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA (2001) 10.03
A simplified acute physiology score for ICU patients. Crit Care Med (1984) 4.55
Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis (2007) 3.30
Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin/tazobactam: a systematic review and meta-analysis. Clin Infect Dis (2012) 2.92
Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis (2012) 2.88
Role for dual individualization with cefmenoxime. Am J Med (1984) 2.29
A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med (2009) 2.17
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med (2012) 2.04
Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections. Int J Antimicrob Agents (2008) 1.92
Continuous infusion versus intermittent administration of meropenem in critically ill patients. J Antimicrob Chemother (1999) 1.92
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2005) 1.89
Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother (2001) 1.87
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia. J Crit Care (2009) 1.77
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother (2009) 1.73
Daptomycin pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis. Crit Care Med (2011) 1.65
First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents (2009) 1.52
Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. Clin J Am Soc Nephrol (2012) 1.48
Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial. Antimicrob Agents Chemother (2007) 1.43
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept. Int J Antimicrob Agents (2010) 1.43
Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection. Antimicrob Agents Chemother (2005) 1.41
Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units. J Antimicrob Chemother (2006) 1.36
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections. Antimicrob Agents Chemother (1996) 1.29
Continuous infusion ceftazidime in intensive care: a randomized controlled trial. J Antimicrob Chemother (1999) 1.24
Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit (2008) 1.22
In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at Forty US Hospitals. Clin Ther (2009) 1.21
Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients. Intensive Care Med (2006) 1.20
Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. Int J Antimicrob Agents (2007) 1.20
Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. CMAJ (2013) 1.19
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia. Crit Care (2012) 1.18
Prospective monitoring of cefepime in intensive care unit adult patients. Crit Care (2010) 1.18
Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration? Crit Care Med (2009) 1.16
The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study. Pharmacotherapy (2011) 1.15
Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia. Int J Antimicrob Agents (2001) 1.13
Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents (2012) 1.11
Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli. Ann Pharmacother (2006) 1.09
Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother (2005) 1.07
Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia. J Antimicrob Chemother (2012) 1.06
Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study. J Crit Care (2008) 1.06
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial. Crit Care (2012) 1.05
Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime. Ann Pharmacother (1994) 1.05
Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion. Int J Antimicrob Agents (2009) 1.04
Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. Int J Antimicrob Agents (2006) 1.02
Pharmacokinetics and pharmacodynamics: optimal antimicrobial therapy in the intensive care unit. Crit Care Clin (2011) 1.02
Pharmacokinetics and pharmacodynamics of intravenous levofloxacin in patients with early-onset ventilator-associated pneumonia. Clin Pharmacokinet (2003) 1.01
Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa. Pharmacotherapy (2003) 0.99
Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents (2012) 0.96
Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data. J Antimicrob Chemother (2010) 0.95
Pharmacokinetics and pharmacodynamics of sequential intravenous and subcutaneous teicoplanin in critically ill patients without vasopressors. Intensive Care Med (2003) 0.95
Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections. J Antimicrob Chemother (2002) 0.94
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients. Int J Antimicrob Agents (2002) 0.92
Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Br J Clin Pharmacol (2010) 0.92
Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients. Clin Ther (2012) 0.92
Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study. Ann Pharmacother (2013) 0.91
Cefepime in critically ill patients: continuous infusion vs. an intermittent dosing regimen. Int J Clin Pharmacol Ther (2005) 0.89
Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study. J Antimicrob Chemother (2006) 0.89
Intermittent and continuous ceftazidime infusion for critically ill trauma patients. Am J Surg (2000) 0.88
Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia. Pharmacotherapy (2001) 0.87
Which reliable pharmacodynamic breakpoint should be advised for ciprofloxacin monotherapy in the hospital setting? A TDM-based retrospective perspective. J Antimicrob Chemother (2006) 0.87
Pharmacokinetics and intrapulmonary diffusion of levofloxacin in critically ill patients with severe community-acquired pneumonia. Crit Care Med (2005) 0.86
[Clinical efficacy of prolonged (4 hour) drip infusion of meropenem against severe pneumonia]. Jpn J Antibiot (2007) 0.86
Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria. Intensive Care Med (2007) 0.86
Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration. J Clin Pharmacol (2005) 0.85
Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Ann Intensive Care (2012) 0.85
Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review. Ann Pharmacother (2012) 0.83
Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia. Pharmacotherapy (2010) 0.83
Experience with extended-infusion meropenem in the management of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii. Int J Antimicrob Agents (2008) 0.83
Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy. J Burn Care Res (2012) 0.81
Pharmacokinetics and pharmacodynamics of levofloxacin in critically ill patients with ventilator-associated pneumonia. Int J Antimicrob Agents (2007) 0.80
Pharmacokinetics and pharmacodynamics of levofloxacin in intensive care patients. Clin Pharmacokinet (2005) 0.79
[Continuous versus intermittent cefepime infusion in critical care. Preliminary results]. Pathol Biol (Paris) (1999) 0.79
Standard versus prolonged doripenem infusion for treatment of gram-negative infections. Ann Pharmacother (2013) 0.78
Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costs. Int J Antimicrob Agents (2011) 0.78
Efficacy of a low dose of cefotaxime in serious chest infections. Chest (1992) 0.78
Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration. Jpn J Antibiot (2008) 0.78
Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria. Ann Pharmacother (2009) 0.78
[Pharmacodynamic interest of ceftazidime continuous infusion vs intermittent bolus administration in patients with severe nosocomial pneumonia]. Pathol Biol (Paris) (2005) 0.76
The optimal dosage of ceftazidime for severe lower respiratory tract infections. J Antimicrob Chemother (1993) 0.76
Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit. Int J Antimicrob Agents (2007) 0.76
Timentin in the treatment of nosocomial bronchopulmonary infections in intensive care units. J Antimicrob Chemother (1986) 0.76
Vital signs after cardiac arrest following withdrawal of life-sustaining therapy: a multicenter prospective observational study. Crit Care Med (2014) 5.07
Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med (2008) 5.06
Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care Med (2014) 4.11
The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med (2014) 3.29
Prone ventilation reduces mortality in patients with acute respiratory failure and severe hypoxemia: systematic review and meta-analysis. Intensive Care Med (2010) 2.88
Medical admission order sets to improve deep vein thrombosis prophylaxis rates and other outcomes. J Hosp Med (2009) 2.49
Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis. BMJ (2007) 2.33
Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest (2013) 2.24
Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study. Intensive Care Med (2007) 2.20
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*. Crit Care Med (2015) 2.16
High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis. Crit Care Med (2010) 1.77
Transfusion triggers for guiding RBC transfusion for cardiovascular surgery: a systematic review and meta-analysis*. Crit Care Med (2014) 1.61
High-frequency oscillation in adults: a utilization review. Crit Care Med (2011) 1.55
Knowledge translation interventions for critically ill patients: a systematic review*. Crit Care Med (2013) 1.53
Discordance between perception and treatment practices associated with intensive care unit-acquired bacteriuria and funguria: a Canadian physician survey. Crit Care Med (2008) 1.48
Coenrollment in a randomized trial of high-frequency oscillation: prevalence, patterns, predictors, and outcomes*. Crit Care Med (2015) 1.41
The use of wireless e-mail to improve healthcare team communication. J Am Med Inform Assoc (2009) 1.39
Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care (2012) 1.28
Long-term outcomes and clinical predictors of hospital mortality in very long stay intensive care unit patients: a cohort study. Crit Care (2006) 1.15
Risk of chronic dialysis and death following acute kidney injury. Am J Med (2012) 1.12
Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-a prospective multicenter observational study. J Crit Care (2011) 1.08
The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol (2010) 1.07
Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observational studies. Crit Care Med (2011) 1.01
Timing the initiation of renal replacement therapy for acute kidney injury in Canadian intensive care units: a multicentre observational study. Can J Anaesth (2012) 0.98
Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients. Pharmacotherapy (2005) 0.96
Drotrecogin alfa (activated) in severe sepsis. N Engl J Med (2006) 0.93
Patients' preferences for enrolment into critical-care trials. Intensive Care Med (2009) 0.91
Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement. Clin Pharmacokinet (2015) 0.90
Automated weaning and SBT systems versus non-automated weaning strategies for weaning time in invasively ventilated critically ill adults. Cochrane Database Syst Rev (2014) 0.89
Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study. Crit Care (2006) 0.89
The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest (2013) 0.89
High-frequency ventilation versus conventional ventilation for treatment of acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev (2013) 0.89
Epidemiology of acute kidney injury in Canadian critical care units: a prospective cohort study. Can J Anaesth (2012) 0.89
Drotrecogin alfa (activated): down and not out, but not really in either. Crit Care (2006) 0.87
Pressure-Controlled vs Volume-Controlled Ventilation in Acute Respiratory Failure: A Physiology-Based Narrative and Systematic Review. Chest (2015) 0.87
Do we need a pharmacist in the ICU? Intensive Care Med (2015) 0.86
Surrogate decision makers' attitudes towards research decision making for critically ill patients. Intensive Care Med (2012) 0.85
Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data. Crit Care (2010) 0.83
Corticosteroid use in the intensive care unit: a survey of intensivists. Can J Anaesth (2013) 0.83
Critical illness in homeless persons is poorly studied: a systematic review of the literature. Intensive Care Med (2013) 0.83
Allergic and hypersensitivity reactions in the intensive care unit. Crit Care Med (2010) 0.81
Automated weaning and spontaneous breathing trial systems versus non-automated weaning strategies for discontinuation time in invasively ventilated postoperative adults. Cochrane Database Syst Rev (2014) 0.80
Prone position ventilation for community-acquired pneumonia. J Formos Med Assoc (2008) 0.78
Previous cultures are not clinically useful for guiding empiric antibiotics in suspected ventilator-associated pneumonia: secondary analysis from a randomized trial. J Crit Care (2008) 0.78
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 0.78
Is nosocomial infection really the major cause of death in sepsis? Crit Care (2014) 0.77
Medical admission order sets: effective, practical, generalizable--but not perfect. J Hosp Med (2009) 0.76
Severe acute respiratory syndrome (SARS): the pharmacist's role. Pharmacotherapy (2004) 0.76
"Stop right there...I gotta know right now!" Do steroids really help for CAP? Am J Respir Crit Care Med (2005) 0.76
Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death. Crit Care (2006) 0.76
High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis--addendum. Crit Care Med (2010) 0.75
Review: fenoldopam reduces acute kidney injury and death in critical illness. ACP J Club (2007) 0.75
The authors reply. Crit Care Med (2014) 0.75
The authors reply. Crit Care Med (2014) 0.75
Decontamination of the digestive tract in ICU patients. N Engl J Med (2009) 0.75
Effect of prone positioning in patients with acute respiratory distress syndrome and high Simplified Acute Physiology Score II. Crit Care Med (2008) 0.75
Inter-hospital transfers and outcomes of critically ill patients with severe acute kidney injury: a multicenter cohort study. Crit Care (2014) 0.75
Nurse- vs nomogram-directed glucose control in a cardiovascular intensive care unit. Am J Crit Care (2012) 0.75
High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome. Cochrane Database Syst Rev (2016) 0.75
The Postcardiac Arrest Consult Team: Impact on Hospital Care Processes for Out-of-Hospital Cardiac Arrest Patients. Crit Care Med (2016) 0.75
Prolonged time to alarm in infusion devices operated at low flow rates. Crit Care Med (2008) 0.75